Cargando…

Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients

Neutrophil gelatinase-associated lipocalin (NGAL) may be an early marker of acute kidney injury (AKI), but elevated NGAL occurs in a wide range of systemic diseases. Because intensive care patients have high levels of comorbidity, our objective was to conduct a systematic review of the literature to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hjortrup, Peter B, Haase, Nicolai, Wetterslev, Mik, Perner, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672520/
https://www.ncbi.nlm.nih.gov/pubmed/23680259
http://dx.doi.org/10.1186/cc11855
_version_ 1782272116171735040
author Hjortrup, Peter B
Haase, Nicolai
Wetterslev, Mik
Perner, Anders
author_facet Hjortrup, Peter B
Haase, Nicolai
Wetterslev, Mik
Perner, Anders
author_sort Hjortrup, Peter B
collection PubMed
description Neutrophil gelatinase-associated lipocalin (NGAL) may be an early marker of acute kidney injury (AKI), but elevated NGAL occurs in a wide range of systemic diseases. Because intensive care patients have high levels of comorbidity, our objective was to conduct a systematic review of the literature to evaluate the value of plasma and urinary NGAL to predict AKI in these patients. We conducted a systematic electronic literature search of MEDLINE through PubMed, EMBASE, and Cochrane Library for all English language research publications evaluating the predictive value of plasma or urinary NGAL (or both) for AKI in adult intensive care patients. Two authors independently extracted data by using a standardized extraction sheet including study characteristics, type of NGAL measurements, and type of outcome measures. The primary summary measure was area under receiver operating characteristic curve (AuROC) for NGAL to predict study outcomes. Eleven studies with a total of 2,875 (range of 20 to 632) participants were included: seven studies assessed urinary NGAL and six assessed plasma NGAL. The included studies varied in design, including observation period from NGAL sampling to AKI follow-up (range of 12 hours to 7 days), definition of baseline creatinine value, and urinary NGAL quantification method (normalizing to urinary creatinine or absolute concentration). AuROC values for the prediction of AKI ranged from 0.54 to 0.98. Five studies reported AuROC for use of renal replacement therapy ranging from 0.73 to 0.89, and four studies reported AuROC for mortality ranging from 0.58 to 0.83. There were no differences in the predictive values of urinary and plasma NGAL. The heterogeneity in study design and results made it difficult to evaluate the value of NGAL to predict AKI in intensive care patients. NGAL seems to have reasonable value in predicting use of renal replacement therapy but not mortality.
format Online
Article
Text
id pubmed-3672520
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36725202014-04-24 Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients Hjortrup, Peter B Haase, Nicolai Wetterslev, Mik Perner, Anders Crit Care Review Neutrophil gelatinase-associated lipocalin (NGAL) may be an early marker of acute kidney injury (AKI), but elevated NGAL occurs in a wide range of systemic diseases. Because intensive care patients have high levels of comorbidity, our objective was to conduct a systematic review of the literature to evaluate the value of plasma and urinary NGAL to predict AKI in these patients. We conducted a systematic electronic literature search of MEDLINE through PubMed, EMBASE, and Cochrane Library for all English language research publications evaluating the predictive value of plasma or urinary NGAL (or both) for AKI in adult intensive care patients. Two authors independently extracted data by using a standardized extraction sheet including study characteristics, type of NGAL measurements, and type of outcome measures. The primary summary measure was area under receiver operating characteristic curve (AuROC) for NGAL to predict study outcomes. Eleven studies with a total of 2,875 (range of 20 to 632) participants were included: seven studies assessed urinary NGAL and six assessed plasma NGAL. The included studies varied in design, including observation period from NGAL sampling to AKI follow-up (range of 12 hours to 7 days), definition of baseline creatinine value, and urinary NGAL quantification method (normalizing to urinary creatinine or absolute concentration). AuROC values for the prediction of AKI ranged from 0.54 to 0.98. Five studies reported AuROC for use of renal replacement therapy ranging from 0.73 to 0.89, and four studies reported AuROC for mortality ranging from 0.58 to 0.83. There were no differences in the predictive values of urinary and plasma NGAL. The heterogeneity in study design and results made it difficult to evaluate the value of NGAL to predict AKI in intensive care patients. NGAL seems to have reasonable value in predicting use of renal replacement therapy but not mortality. BioMed Central 2013 2013-04-24 /pmc/articles/PMC3672520/ /pubmed/23680259 http://dx.doi.org/10.1186/cc11855 Text en Copyright © 2013 BioMed Central Ltd
spellingShingle Review
Hjortrup, Peter B
Haase, Nicolai
Wetterslev, Mik
Perner, Anders
Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients
title Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients
title_full Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients
title_fullStr Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients
title_full_unstemmed Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients
title_short Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients
title_sort clinical review: predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672520/
https://www.ncbi.nlm.nih.gov/pubmed/23680259
http://dx.doi.org/10.1186/cc11855
work_keys_str_mv AT hjortruppeterb clinicalreviewpredictivevalueofneutrophilgelatinaseassociatedlipocalinforacutekidneyinjuryinintensivecarepatients
AT haasenicolai clinicalreviewpredictivevalueofneutrophilgelatinaseassociatedlipocalinforacutekidneyinjuryinintensivecarepatients
AT wetterslevmik clinicalreviewpredictivevalueofneutrophilgelatinaseassociatedlipocalinforacutekidneyinjuryinintensivecarepatients
AT perneranders clinicalreviewpredictivevalueofneutrophilgelatinaseassociatedlipocalinforacutekidneyinjuryinintensivecarepatients